Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-07 09:12 am Unchanged | 2025-02-07 | 13G | Carmell Therapeutics Corporation CTCX | Newlin Investment Company 1, LLC | 1,279,941 4.200% | 0 (Unchanged) | Filing History |
| 2025-01-08 09:05 am Purchase | 2024-12-31 | 13G | Carmell Therapeutics Corporation CTCX | Newlin Investment Company 1, LLC | 1,279,941 6.100% | 30,879 (+2.47%) | Filing History |
| 2024-12-06 4:16 pm Sale | 2024-11-30 | 13G | Carmell Therapeutics Corporation CTCX | METEORA CAPITAL LLC | 0 0.000% | -1,697,714 (Position Closed) | Filing History |
| 2024-11-14 2:48 pm Sale | 2024-09-30 | 13G | Carmell Therapeutics Corporation CTCX | METEORA CAPITAL LLC | 1,697,714 8.120% | -45,309 (-2.60%) | Filing History |
| 2024-04-18 3:03 pm Purchase | 2024-04-04 | 13G | Carmell Therapeutics Corporation CTCX | SANDSTONE Asset Management | 1,017,615 4.945% | 1,017,615 (New Position) | Filing History |
| 2024-02-14 4:13 pm Purchase | 2023-12-31 | 13G | Carmell Therapeutics Corporation CTCX | P SCHOENFELD ASSET MANAGEMENT LP | 125,000 0.500% | 125,000 (New Position) | Filing History |
| 2024-02-14 3:42 pm Purchase | 2023-12-31 | 13G | Carmell Therapeutics Corporation CTCX | Antara Capital LP | 371,250 1.600% | 371,250 (New Position) | Filing History |
| 2024-02-14 12:54 pm Purchase | 2023-12-31 | 13G | Carmell Therapeutics Corporation CTCX | METEORA CAPITAL LLC | 1,743,023 7.550% | 1,743,023 (New Position) | Filing History |
| 2024-02-14 06:21 am Unchanged | 2023-12-31 | 13G | Carmell Therapeutics Corporation CTCX | BALYASNY ASSET MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-14 06:09 am Unchanged | 2023-12-31 | 13G | Carmell Therapeutics Corporation CTCX | OZ Management LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-12 4:42 pm Sale | 2023-12-29 | 13G | Alpha Healthcare Acquisition Corp. III ALPA | UBS OCONNOR LLC | 0 0.000% | -1,485,000 (Position Closed) | Filing History |
| 2024-02-07 2:18 pm Purchase | 2023-12-31 | 13G | Carmell Therapeutics Corporation CTCX | Linden Capital L.P. | 371,248 1.600% | 371,248 (New Position) | Filing History |
| 2024-02-06 7:59 pm Purchase | 2023-12-31 | 13G | Carmell Therapeutics Corporation CTCX | Newlin Investment Company 1, LLC | 1,249,062 5.400% | 1,249,062 (New Position) | Filing History |
| 2024-02-05 4:27 pm Purchase | 2023-12-31 | 13G | Carmell Therapeutics Corporation CTCX | Integrated Core Strategies (US) LLC | 235,414 1.000% | 235,414 (New Position) | Filing History |
| 2023-11-21 5:24 pm Unchanged | 2023-11-17 | 13G | Carmell Therapeutics Corporation CTCX | Shukla Rajiv | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-03-23 2:45 pm Sale | 2022-11-01 | 13G | Alpha Healthcare Acquisition Corp. III ALPAU | SANDSTONE Asset Management | 1,020,520 6.400% | -29,480 (-2.81%) | Filing History |
| 2023-03-21 3:33 pm Purchase | 2021-07-27 | 13G | Alpha Healthcare Acquisition Corp. III ALPAU | SANDSTONE Asset Management | 1,050,000 7.000% | 1,050,000 (New Position) | Filing History |
| 2023-02-14 12:45 pm Unchanged | 2022-12-30 | 13G | Alpha Healthcare Acquisition Corp. III ALPA | UBS OCONNOR LLC | 1,485,000 9.330% | 0 (Unchanged) | Filing History |
| 2023-02-14 12:20 pm Unchanged | 2022-12-31 | 13G | Alpha Healthcare Acquisition Corp. III ALPA | OZ Management LP | 1,471,470 9.250% | 0 (Unchanged) | Filing History |
| 2023-02-14 07:33 am Purchase | 2022-12-31 | 13G | Alpha Healthcare Acquisition Corp. III ALPAU | Antara Capital LP | 785,000 5.100% | 785,000 (New Position) | Filing History |